Literature DB >> 23376065

TRAF1 phosphorylation on Serine 139 modulates NF-κB activity downstream of 4-1BB in T cells.

N A Eustache Oussa1, Youssouf Soumounou, Laurent Sabbagh.   

Abstract

The Tumour Necrosis Factor (TNF) Receptor-associated factor-1 (TRAF1) adaptor protein is a key component in initiating intracellular signalling pathways downstream of TNF receptors (TNFR). More importantly, TRAF1 has a pattern of expression restricted primarily to lymphoid cells and plays an important role in lymphocyte survival. TRAF1 has been shown to be phosphorylated on Serine 139, consequently inhibiting NF-κB activation downstream of TNFR2 when expressed in HeLa cells. We have previously demonstrated that TRAF1 cooperates with the TNFR family member 4-1BB to mediate signalling in T cells. However, the impact of TRAF1 phosphorylation on events downstream of 4-1BB in T cells remained to be defined. Using a proteomics approach we demonstrate that TANK-binding kinase 1 (TBK1) preferentially associates with the TRAF1 Serine 139 to Alanine (S139A) mutant. TBK1 is a kinase that functions upstream of NIK and IKK in the activation of the NF-κB pathway. When TRAF1-deficient CD8 T cells were reconstituted with the TRAF1 S139A mutant, we observed more sustained levels of IκBα degradation in response to 4-1BB stimulation in contrast to cells expressing either TRAF1 wild-type or TRAF1 S139D phospho-mimetic mutant. Together, these findings define the importance of the basal phosphorylation state of the TRAF1 Serine 139 residue in coordinating signalling events downstream of 4-1BB in primary T cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376065     DOI: 10.1016/j.bbrc.2013.01.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  CD40/TRAF1 decreases synovial cell apoptosis in patients with rheumatoid arthritis through JNK/NF-κB pathway.

Authors:  Tao Cheng; Jian Wu; Yaozeng Xu; Cuiping Liu; Huayong Zhang; Mingjun Wang
Journal:  J Bone Miner Metab       Date:  2022-08-12       Impact factor: 2.976

2.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

Review 3.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

4.  TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.

Authors:  X-F Zhang; R Zhang; L Huang; P-X Wang; Y Zhang; D-S Jiang; L-H Zhu; S Tian; X-D Zhang; H Li
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

5.  CD137 Signaling Promotes Endothelial Apoptosis by Inhibiting Nrf2 Pathway, and Upregulating NF-κB Pathway.

Authors:  Tianxin Geng; Yang Yan; Yue Zhang; Liangjie Xu; Guangyao Zang; Jin Chuan Yan
Journal:  Mediators Inflamm       Date:  2020-06-06       Impact factor: 4.711

Review 6.  CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs.

Authors:  Juan M Zapata; Gema Perez-Chacon; Pablo Carr-Baena; Ivan Martinez-Forero; Arantza Azpilikueta; Itziar Otano; Ignacio Melero
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

7.  CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway.

Authors:  Jinchuan Yan; Yunjie Yin; Wei Zhong; Cuiping Wang; Zhongqun Wang
Journal:  Mediators Inflamm       Date:  2015-10-27       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.